Walgreens Boots Alliance (NASDAQ:WBA) announced its earnings results on Thursday. The pharmacy operator reported $1.17 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.02 by $0.15, RTT News reports. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The company had revenue of $34.26 billion for the quarter, compared to analyst estimates of $33.39 billion. During the same period in the prior year, the company posted $1.02 EPS. Walgreens Boots Alliance’s quarterly revenue was up 12.8% on a year-over-year basis.
Shares of NASDAQ WBA opened at $47.26 on Thursday. Walgreens Boots Alliance has a 12 month low of $33.36 and a 12 month high of $57.05. The company has a market cap of $40.88 billion, a price-to-earnings ratio of 17.90, a P/E/G ratio of 1.41 and a beta of 0.49. The company has a quick ratio of 0.53, a current ratio of 0.77 and a debt-to-equity ratio of 0.34. The business has a fifty day simple moving average of $48.70 and a 200-day simple moving average of $50.83.
A number of brokerages have recently weighed in on WBA. Deutsche Bank Aktiengesellschaft lowered their price target on Walgreens Boots Alliance from $55.00 to $52.00 and set a “hold” rating for the company in a report on Friday, July 2nd. Truist Securities lowered their price objective on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating for the company in a research note on Friday, July 2nd. Robert W. Baird restated a “buy” rating and set a $68.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, September 3rd. Evercore ISI restated a “hold” rating and set a $52.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, July 2nd. Finally, Credit Suisse Group restated a “hold” rating and set a $48.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, September 24th. Twelve investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $52.81.
Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.
Recommended Story: Dividend Aristocrat Index
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.